priZm Therapeutics
  • Home
  • PriZmTX
  • About Us
  • MCT8 Deficiency (AHDS)
  • News
  • Careers
  • Contact
  • Clinical Study
  • SRW101
logo

Elliot Joseph

Slide Elliot Joseph Elliot Joseph most recently has served for 11 years as CEO of Hartford HealthCare (HHC) a large, highly integrated regional healthcare delivery system. Under his leadership HHC grew annual revenue from $1 billion to $4.2 billion, with operating performance improving from breakeven to 5% operating margin and 10% EBITDA margins while securing bond ratings in A stable-positive category. Today, HHC is the largest home care company and the largest behavioral health company in Connecticut providing over 300 sites of care including a broad footprint in ambulatory surgery, diagnostic imaging and urgent care. Additionally, HHC built an 800 member medical group and created a clinically integrated organization, Integrated Care Partners with over 2000 providers.

Recently, Mr. Joseph established a Joint Venture Medicare Advantage Plan with Tufts health plan to serve CT. Mr. Joseph is currently serving as a board member to several private equity portfolio companies including TPG Growth and Chicago Pacific Founders. He is also an advisor to Triple Tree and Epsilon. He serves McKinsey and Co as a faculty member for the Bower Forum. Additionally, he serves as Chairman of the Press Ganey Advisory Board and the Health Insights Board. Previously, he has served in board and advisory roles with the American Hospital Association, The Bushnell Performing Arts Center, Connecticut Hospital Association Board and Finance Committee Chair, Greater New York Hospital Association, GNYHA Ventures Corporation, and has chaired the Hartford HealthCare Indemnity Services LTD Board.

Mr. Joseph holds a Masters of Health Services Administration from the University of Michigan (where he serves on the Griffith Leadership Center Advisory Board and is on the search committee to recruit a new chair for the Department of Health management and Policy), Wharton School CEO Program for Healthcare Leadership, and a Bachelor of Arts from the State University of New York.
On December 30, 2020   /    

About This Sidebar

  • To edit this sidebar, go to admin backend's Appearance -> Widgets and place widgets into the BlogSidebar Widget Area

A late-stage clinical biotech company developing therapies for ultra-rare pediatric orphan diseases

 

 

 

 

 

© 2023 PriZm, LLC
Back to Top